MedTrace Logo

Re-Irradiation of Progressive or Recurrent DIPG

NCT03126266 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 27

Last updated 2024-12-05

No results posted yet for this study

Summary

This is a single-arm, non-randomized study of re-irradiation of diffuse intrinsic pontine glioma (DIPG)

Conditions

  • Recurrent or Progressive Diffuse Intrinsic Pontine Glioma

Interventions

RADIATION

re-irradiation

if DIPG has progressed or recurred at 180 days or later from completion of primary radiation therapy, a second course of radiation therapy will be given

Sponsors & Collaborators

  • University of Calgary

    lead OTHER

Principal Investigators

  • Lucie Lafay-Cousin, MD · University of Calgary

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-15
Primary Completion
2024-11-20
Completion
2024-11-25

Countries

  • Australia
  • Canada
  • New Zealand

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03126266 on ClinicalTrials.gov